Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biotelliga is a New Zealand-based biotechnology company that leverages fungal biology to develop sustainable solutions for agriculture and human health. The company utilizes a proprietary platform to identify and produce bioactive compounds from fungi, targeting applications in crop protection and therapeutic development. In the healthcare sector, Biotelliga focuses on discovering novel anti-fungal agents and anti-cancer treatments derived from unique fungal strains. Their approach combines traditional microbiology with modern genomic and proteomic tools to accelerate the discovery of natural products. The company aims to address the growing need for effective, natural alternatives to synthetic chemicals in both the clinic and the field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotelliga.